Expression of cytosolic NADP +-dependent isocitrate dehydrogenase in melanocytes and its role as an antioxidant

Journal of Dermatological Science

Volumn 65, Issue 2, 2012, Pages 118-125

  Kim, Ji Young ^a   Shin, Jae Yong ^a   Kim, Miri ^a   Hann, Seung Kyung ^b   Oh, Sang Ho ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Drs Woo and Hann's Skin Center   (South Korea)

Author keywords

Antioxidant; Cytosolic NADP + dependent isocitrate dehydrogenase; Melanocyte; Oxidant stress; SiRNA; Vitiligo

Indexed keywords

GLUTATHIONE; GLUTATHIONE DISULFIDE; HYDROGEN PEROXIDE; ISOCITRATE DEHYDROGENASE (NADP); MESSENGER RNA; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL IMMORTALIZATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE SILENCING; GENETIC TRANSFECTION; MELANOCYTE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; GLUTATHIONE; HUMANS; ISOCITRATE DEHYDROGENASE; MELANOCYTES; MICE; NECROSIS; OXIDANTS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION; VITILIGO;

EID: 84862816708     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2011.12.007     Document Type: Article

References (50)

1. Shindo Y., Witt E., Han D., Epstein W., Enzymic Packer L. Non-enzymatic antioxidants in epidermis and dermis of human skin. J Invest Dermatol 1994, 102:122-124.
2. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002, 82:47-95.
3. Pinnell S.R. Cutaneous photodamage, oxidative stress, and topical antioxidant protection. J Am Acad Dermatol 2003, 48:1-19. Quiz 20-22.
4. Koshland D.E., Walsh K., LaPorte D.C. Sensitivity of metabolic fluxes to covalent control. Curr Top Cell Regul 1985, 27:13-22.
5. Kirsch M., De Groot H. NAD(P)H, a directly operating antioxidant?. FASEB J 2001, 15:1569-1574.
6. Nakamura H. Thioredoxin and its related molecules: update 2005. Antioxid Redox Signal 2005, 7:823-828.
7. Kemp E.H., Waterman E.A., Weetman A.P. Autoimmune aspects of vitiligo. Autoimmunity 2001, 34:65-77.
8. Ongenae K., Van Geel N., Naeyaert J.M. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res 2003, 16:90-100.
9. Passi S., Grandinetti M., Maggio F., Stancato A., De Luca C. Epidermal oxidative stress in vitiligo. Pigment Cell Res 1998, 11:81-85.
10. 2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Investig Dermatol Symp Proc 1999, 4:91-96.
11. Schallreuter K.U., Wood J.M., Berger J. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 1991, 97:1081-1085.
12. Koca R., Armutcu F., Altinyazar H.C., Gurel A. Oxidant-antioxidant enzymes and lipid peroxidation in generalized vitiligo. Clin Exp Dermatol 2004, 29:406-409.
13. Schallreuter K.U., Chiuchiarelli G., Cemeli E., Elwary S.M., Gillbro J.M., Spencer J.D., et al. Estrogens can contribute to hydrogen peroxide generation and quinone-mediated DNA damage in peripheral blood lymphocytes from patients with vitiligo. J Invest Dermatol 2006, 126:1036-1042.
14. Dell'Anna M.L., Ottaviani M., Albanesi V., Vidolin A.P., Leone G., Ferraro C., et al. Membrane lipid alterations as a possible basis for melanocyte degeneration in vitiligo. J Invest Dermatol 2007, 127:1226-1233.
15. Kim J.Y., Do J.E., Ahn K.J., Noh S., Jee H.J., Oh S.H. Detection of melanocyte autoantigens reacting with autoantibodies in vitiligo patients by proteomics. J Dermatol Sci 2011, 62:202-204.
16. Jo S.H., Lee S.H., Chun H.S., Lee S.M., Koh H.J., Lee S.E., et al. Cellular defense against UVB-induced phototoxicity by cytosolic NADP(+)-dependent isocitrate dehydrogenase. Biochem Biophys Res Commun 2002, 292:542-549.
17. Bennett D.C., Cooper P.J., Hart I.R. A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth. Int J Cancer 1987, 39:414-418.
18. Lee S.M., Koh H.J., Park D.C., Song B.J., Huh T.L., Park J.W. Cytosolic NADP(+)-dependent isocitrate dehydrogenase status modulates oxidative damage to cells. Free Radic Biol Med 2002, 32:1185-1196.
19. Bickers D.R., Athar M. Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol 2006, 126:2565-2575.
20. Briganti S., Picardo M. Antioxidant activity, lipid peroxidation and skin diseases. What's new. J Eur Acad Dermatol Venereol 2003, 17:663-669.
21. Shigenaga M.K., Hagen T.M., Ames B.N. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 1994, 91:10771-10778.
22. Zhou Z., Li C.Y., Li K., Wang T., Zhang B., Gao T.W. Decreased methionine sulphoxide reductase A expression renders melanocytes more sensitive to oxidative stress: a possible cause for melanocyte loss in vitiligo. Br J Dermatol 2009, 161:504-509.
23. Levine R.L., Mosoni L., Berlett B.S., Stadtman E.R. Methionine residues as endogenous antioxidants in proteins. Proc Natl Acad Sci USA 1996, 93:15036-15040.
24. Ogawa F., Sander C.S., Hansel A., Oehrl W., Kasperczyk H., Elsner P., et al. The repair enzyme peptide methionine-S-sulfoxide reductase is expressed in human epidermis and upregulated by UVA radiation. J Invest Dermatol 2006, 126:1128-1134.
25. Schallreuter K.U., Wood J.M. Thioredoxin reductase - its role in epidermal redox status. J Photochem Photobiol B 2001, 64:179-184.
26. Yohn J.J., Norris D.A., Yrastorza D.G., Buno I.J., Leff J.A., Hake S.S., et al. Disparate antioxidant enzyme activities in cultured human cutaneous fibroblasts, keratinocytes, and melanocytes. J Invest Dermatol 1991, 97:405-409.
27. Picardo M., Passi S., Morrone A., Grandinetti M., Di Carlo A., Ippolito F. Antioxidant status in the blood of patients with active vitiligo. Pigment Cell Res 1994, 7:110-115.
28. Jimbow K., Chen H., Park J.S., Thomas P.D. Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. Br J Dermatol 2001, 144:55-65.
29. Kroll T.M., Bommiasamy H., Boissy R.E., Hernandez C., Nickoloff B.J., Mestril R., et al. 4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo. J Invest Dermatol 2005, 124:798-806.
30. Yang F., Boissy R.E. Effects of 4-tertiary butylphenol on the tyrosinase activity in human melanocytes. Pigment Cell Res 1999, 12:237-245.
31. 4-dependent processes. J Invest Dermatol 2001, 116:167-174.
32. Rokos H., Beazley W.D., Schallreuter K.U. Oxidative stress in vitiligo: photo-oxidation of pterins produces H(2)O(2) and pterin-6-carboxylic acid. Biochem Biophys Res Commun 2002, 292:805-811.
33. Schallreuter K.U., Elwary S.M., Gibbons N.C., Rokos H., Wood J.M. Activation/deactivation of acetylcholinesterase by H2O2: more evidence for oxidative stress in vitiligo. Biochem Biophys Res Commun 2004, 315:502-508.
34. Maresca V., Flori E., Briganti S., Mastrofrancesco A., Fabbri C., Mileo A.M., et al. Correlation between melanogenic and catalase activity in in vitro human melanocytes: a synergic strategy against oxidative stress. Pigment Cell Melanoma Res 2008, 21:200-205.
35. Maresca V., Roccella M., Roccella F., Camera E., Del Porto G., Passi S., et al. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol 1997, 109:310-313.
36. Casp C.B., She J.X., McCormack W.T. Genetic association of the catalase gene (CAT) with vitiligo susceptibility. Pigment Cell Res 2002, 15:62-66.
37. Liu L., Li C., Gao J., Li K., Zhang R., Wang G., et al. Promoter variant in the catalase gene is associated with vitiligo in Chinese people. J Invest Dermatol 2010, 130:2647-2653.
38. Jian Z., Li K., Liu L., Zhang Y., Zhou Z., Li C., et al. Heme oxygenase-1 protects human melanocytes from H(2)O(2)-induced oxidative stress via the Nrf2-ARE pathway. J Invest Dermatol 2011, 131:1420-1427.
39. Guan C.P., Wei X.D., Chen H.Y., Zhang L., Zhou M.N., Xu A.E. Abnormal nuclear translocation of nuclear factor-E2 related factor 2 in the lesion of vitiligo. Zhonghua Yi Xue Za Zhi 2008, 88:2403-2406.
40. Jennings G.T., Stevenson P.M. A study of the control of NADP(+)-dependent isocitrate dehydrogenase activity during gonadotropin-induced development of the rat ovary. Eur J Biochem 1991, 198:621-625.
41. +-dependent isocitrate dehydrogenase plays a key role in lipid metabolism. J Biol Chem 2004, 279:39968-39974.
42. +-dependent isocitrate dehydrogenase in ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol 2009, 296:F622-F633.
43. Ronnebaum S.M., Ilkayeva O., Burgess S.C., Joseph J.W., Lu D., Stevens R.D., et al. A pyruvate cycling pathway involving cytosolic NADP-dependent isocitrate dehydrogenase regulates glucose-stimulated insulin secretion. J Biol Chem 2006, 281:30593-30602.
44. Veech R.L., Eggleston L.V., Krebs H.A. The redox state of free nicotinamide-adenine dinucleotide phosphate in the cytoplasm of rat liver. Biochem J 1969, 115:609-619.
45. +-dependent isocitrate dehydrogenase. Free Radic Biol Med 2006, 40:110-119.
46. Kil I.S., Lee Y.S., Bae Y.S., Huh T.L., Park J.W. Modulation of NADP(+)-dependent isocitrate dehydrogenase in aging. Redox Rep 2004, 9:271-277.
47. Bleeker F.E., Lamba S., Leenstra S., Troost D., Hulsebos T., Vandertop W.P., et al. IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. Hum Mutat 2009, 30:7-11.
48. Kang M.R., Kim M.S., Oh J.E., Kim Y.R., Song S.Y., Seo S.I., et al. Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers. Int J Cancer 2009, 125:353-355.
49. Shibata T., Kokubu A., Miyamoto M., Sasajima Y., Yamazaki N. Mutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation. Am J Pathol 2011, 178:1395-1402.
50. Labussiere M., Sanson M., Idbaih A., Delattre J.Y. IDH1 gene mutations: a new paradigm in glioma prognosis and therapy. Oncologist 2010, 15:196-199.